Tag: suite

MONTRÉAL, 08 août 2025 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) annonce la nomination de M. André Courville à titre de Président du Conseil d’administration. Il succèdera ainsi le 30 septembre prochain à M. Alain Rhéaume, qui a annoncé sa retraite en juin dernier après 15 ans de contribution au Conseil, dont huit à titre de Président.

MONTRÉAL, 08 août 2025 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) annonce ses résultats pour le deuxième trimestre de l'exercice 2025.

CALGARY, Alberta, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calfrac Well Services Ltd. (“Calfrac” or “the Company”) (TSX: CFW) announces its financial and operating results for the three and six months ended June 30, 2025. The following press release should be read in conjunction with the management’s discussion and analysis and interim consolidated financial statements and notes thereto as at June 30, 2025. Readers should also refer to the “Forward-looking statements” legal advisory and the section regarding “Non-GAAP Measures” at the end of this press release. All financial amounts and measures are expressed in Canadian dollars unless otherwise indicated. Additional information about Calfrac is available on the SEDAR+ website at www.sedarplus.ca, including the Company’s Annual Information Form for the year ended December 31, 2024.

MOUNTAIN VIEW, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the pricing of its upsized initial public offering of 16,666,667 shares of its common stock at a public offering price of $19.00 per share. All of the shares of common stock are being offered by Heartflow. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Heartflow, are expected to be approximately $316.7 million. In addition, Heartflow has granted the underwriters a 30-day option to purchase up to an additional 2,500,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on August 8, 2025 under the ticker symbol "HTFL.” The closing of the offering is expected to occur on August 11, 2025, subject to the satisfaction of customary closing conditions.

SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Rocket Pharmaceuticals class action lawsuit – captioned Ho v. Rocket Pharmaceuticals, Inc., No. 25-cv-10049 (D.N.J.) – seeks to represent purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities and charges Rocket Pharmaceuticals and one of Rocket Pharmaceuticals’ top executives with violations of the Securities Exchange Act of 1934. A subsequently filed case is captioned Yankov v. Rocket Pharmaceuticals, Inc., No. 25-cv-13532 (D.N.J.).

Annual Recurring Revenue (ARR)⁽¹⁾ up 55% YoY to $79.6 million
Total Revenue up 47% YoY to $23.9 million
Adjusted EBITDA⁽¹⁾ up 50% YoY to $6.3 million

ROUGEMONT, Québec, 07 août 2025 (GLOBE NEWSWIRE) -- Industries Lassonde inc. (TSX : LAS.A) (« Lassonde » ou la « Société ») a annoncé aujourd'hui ses résultats financiers pour le deuxième trimestre de l’exercice 2025.

MONTRÉAL, 07 août 2025 (GLOBE NEWSWIRE) -- Saputo inc. (TSX: SAP) (nous, Saputo ou la Société) a divulgué aujourd’hui ses résultats financiers pour le premier trimestre de l’exercice 2026, clos le 30 juin 2025. À moins d’avis contraire, tous les montants inclus dans ce communiqué de presse sont exprimés en millions de dollars canadiens (CAD), sauf les données par action, et sont présentés conformément aux Normes internationales d’information financière (IFRS).